We are pleased to announce that a clinical trial has been developed to address IBS. A University College of Pharmacy developed this breakthrough compound with potential curative effects. The trial will start on August 12th at the Center for Immunology Science in West Los Angeles. We are looking for volunteers to come to our laboratory for a 1-hour seminar, receive a 30-day supply of the compound, and once a week, fill out an online journal that will take about 5 minutes each week. The trial will only last 30 days. Please note that the compound is 100% non-toxic, vegan and safe. This is phase 2 of the trial.
You must have a letter from your doctor diagnosing you with IBS. Payment comes after you have completed the trial.
If you're interested, please reply to this email or go to https://centerforimmunologyscience.com/ for more details.
